Market Cap (In CNY)
8.36 Billion
Revenue (In CNY)
1.26 Billion
Net Income (In CNY)
289.41 Million
Avg. Volume
2.27 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 17.33-26.8
- PE
- -
- EPS
- -
- Beta Value
- -0.173
- ISIN
- CNE1000042S4
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Dingjun Chu
- Employee Count
- -
- Website
- https://www.aurisco.com
- Ipo Date
- 2020-09-21
- Details
- Aurisco Pharmaceutical Co.,Ltd. engages in research, manufacturing, and marketing of intermediates, specialty active pharmaceutical ingredients (API's), and formulations catering to the pharmaceutical market worldwide. The company offers steroids, oncology, antiretroviral, and other APIs and intermediates. It also provides contract manufacturing services and related development works for chemicals, intermediates, and API's. Aurisco Pharmaceutical Co.,Ltd. was founded in 1998 and is headquartered in Tiantai, China.
More Stocks
-
7501Tiemco Ltd.
7501
-
RARE
-
2941
-
QQ
-
SOLSOL S.p.A.
SOL
-
DIB
-
7746
-
MILDEFMilDef Group AB (publ)
MILDEF